Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1270
Trial Sponsor
Clinical Trial Start Date
2011
0Primary Completion Date
2013
0Study Completion Date
December 19, 2017
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
Implantation of the SAPIEN™ Transcatheter Heart Valve (THV) in the Pulmonic Position0
Last Updated
November 20, 2018
0Study summary
The purpose of this registry is to retrospectively and prospectively obtain clinical data in consecutively treated patients, in order to demonstrate that the commercially available Edwards SAPIEN Valve with the RF3 delivery system is a safe and effective treatment for patients with pulmonary regurgitation or stenosis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
